Paracentesis for Cirrhotic Ascites

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment: Second Edition

Volumn , Issue , 2007, Pages 241-250

  Morillas, Rosa María ^a   Santos, Justiniano ^a   Montoliu, Silvia ^a   Planas, Ramon ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Ascites; Cirrhosis; Hyponatremia; Paracentesis; Portosystemic shunt

Indexed keywords

EID: 84889324754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987476.ch19     Document Type: Chapter

References (53)

1. Ginès P, Qintero E, Arroyo V et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7:122-8.
2. Llach J, Ginès P, Arroyo V et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94:482-7.
3. Pérez-Ayuso RM, Arroyo V, Planas R et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhotics with ascites. Gastroenterology 1983; 84:961-8.
4. Arroyo V, Ginès P, Planas R, Panés J, Rodés J. Management of patients with cirrhosis and ascites. Semin Liver Dis 1986; 6:353-69.
5. LeVeen HH, Christoudias G, Moon JP. Peritoneovenous shunting for ascites. Ann Surg 1974; 180:580-91.
6. Smajda C, Franco D. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis: a prospective study in 140 patients. Ann Surg 1985; 201:488.
7. Stanley MM, Ochi S, Lee KK et al. and the Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321:1632-8.
8. Bernhoft RA, Pellegrini CA, Way LW. Peritoneovenous shunt for refractory ascites: operative complications and long-term results. Arch Surg 1982; 117:631-5.
9. Quintero E, Ginès P, Arroyo V et al. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985; i: 611-12.
10. Ginès P, Arroyo V, Quintero E et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93:234-41.
11. Salerno F, Badalamenti S, Incerti P, Jempini S, Restelli B, Bruno S. Repeated paracentesis and IV albumin infusion to treat "tense" ascites in cirrhotic patients: a safe alternative therapy. J Hepatol 1987; 5:102-8.
12. Hagève H, Ink O, Ducreux G, Pelletier G, Buffet C, Etienne JP. Traitement de l'ascite chez les malades atteints de cirrhose sans hyponatrémie ni insuffisance rénale. Gastroenterol Clin Biol 1992; 16:751-5.
13. Acharya SK, Balwinder S, Padhee AK et al. Large volume paracentesis and intravenous dextran to treat tense ascites. J Clin Gastroenterol 1992; 14:31-5.
14. Solà R, Vila C, Andreu M et al. Total paracentesis with dextran-40 vs diuretics in the treatment of ascites in cirrhosis. A randomized controlled trial. J Hepatol 1994; 20:282-8.
15. Titó Ll, Ginès P, Arroyo V et al. Total paracentesis associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology 1990; 98:146-51.
16. Moore KP, Wong F, Ginès P et al. The management of ascites in cirrhosis: report on the Consensus Conference of the International Ascites Club. Hepatology 2003; 38:258-66.
17. Fernández-Esparrach G, Guevara M, Sort P et al. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double blind trial of spironolactone versus placebo. J Hepatol 1997; 26:614-20.
18. Gines P, Tito Ll, Arroyo V et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94:1493-502.
19. García-Compean D, Villareal JC, Cuevas HB et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. Liver 1993; 13:233-8.
20. Simon DM, Mc Cain JR, Bonkovsky HL, Wells JO, Hartle DK, Galambos JT. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on the renal and hormonal function. Hepatology 1987; 7:423-9.
21. Panos MZ, Moore K, Vlavianos P et al. Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size. Hepatology 1990; 11:662-7.
22. Terg G, Berreta J, Abecasis R, Romero G, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option. Dig Dis Sci 1992; 37:79-83.
23. Luca A, Feu F, García-Pagán JC et al. Cambios hemodinámicos y humorales inmediatos y a las 24 horas de la paracentesis total con y sin albúmina. Gastroenterol Hepatol 1993; 16:230.
24. Pozzi M, Osculati Gl, Boari G et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology 1994; 106:709-19.
25. Luca A, Fue F, García-Pagán JC et al. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 1994; 20:30-3.
26. Kao HW, Rakov NE, Savage E, Reynolds TB. The effect of large volume paracentesis on plasma volume: a cause of hypovolemia? Hepatology 1985; 5:403-7.
27. Pinto PC, Amerian J, Reynolds TB. Large-volume paracentesis in nonedematous patients with tense ascites: its effects on intravascular volume. Hepatology 1988; 8:207-10.
28. Gentile S, Angelico M, Bologna E, Capocaccia L. Clinical, biochemical and hormonal changes after a single, largevolume paracentesis in cirrhosis with ascites. Am J Gastroenterol 1989; 84:279-84.
29. Planas R, Ginès P, Arroyo V et al. Dextran 70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis: results of a randomized study. Gastroenterology 1990; 99:1736-44.
30. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incierti P. Randomized comparative study of Hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13:707-13.
31. Fassio E, Terg R, Landeira G et al. Paracentesis with Dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992; 14:310-16.
32. Cabrera J, Inglada L, Quintero E et al. Large-volume paracentesis and intravenous saline: effects on the renin-angiotensin system. Hepatology 1991; 14:1025-8.
33. Ginès A, Fernández-Esparrach G, Monescillo A et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111:1002-10.
34. Salerno F, Badalamenti S, Moser P et al. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of largevolume paracentesis. Gastroenterology 1990; 98:1063-70.
35. Wang SS, Lu CW, Chao Y et al. Total paracentesis in nonalcoholic cirrhotics with massive ascites: mid-term effects on systemic and hepatic haemodynamics and renal function. J Gastroenterol Hepatol 1994; 9:592-6.
36. Saló J, Ginès A, Ginès P et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol 1997; 26:645-53.
37. Ruiz Del Arbol L, Monescillo A, Jiménez W et al. Paracentesisinduced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113:579-86.
38. Pozzi M, Carugo S, Boari G et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:1131-7.
39. Ginès P, Arroyo V, Vargas V et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325:829-35.
40. Ginès A, Planas R, Angeli P et al. Treatment of patients with cirrhosis and refractory ascites using the LeVeen shunt with titanium tip: comparison with therapeutic paracentesis. Hepatology 1995; 22:124-31.
41. Arroyo V, Ginès P. TIPS and refractory ascites. Lessons from the recent history of ascites therapy. J Hepatol 1996; 25:221-3.
42. Wong F, Sniderman K, Liu P et al. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122:816-22.
43. Azoulay D, Castaing D, Dennison A et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19:129-32.
44. Somberg KA, Lake JR, Tomlanovich et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21:709-16.
45. Quiroga J, Sangro B, Nuñez M et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995; 21:986-94.
46. Ochss A, Rössle M, Haag K et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-7.
47. Guevara M, Ginès P, Bandi JC et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28:416-22.
48. Arroyo V, Cárdenas A. TIPS in the treatment of refractory ascites. In: Arroyo V, Bosch J, Bruguera M, Rodés J, Sánchez Tapias JM, eds. Treatment of Liver Diseases. Barcelona: Masson SA, 1999; 43-51.
49. Lebrec D, Giuily N, Hadengue A et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites. J Hepatol 1996; 25:135-44.
50. Rössle M, Ochs A, Gülberg V et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-6.
51. Ginès P, Uriz J, Calahorra B et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123:1839-47.
52. Sanyal AJ, Genning C, Eddy KJ et al. The North American Study for the treatment of refractory ascites. Gastroenterology 2003; 124:634-41.
53. Salerno F, Merli M, Riggio O et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40(3):629-35.